Johnson & Johnson Reports Core Pharmaceutical Sales for H1 2019
Jul 17, 2019 11:07
CST Updated
11:07
Novartis
Drug Development and Manufacturing
Johnson & Johnson Core Drug Sales in H1 2019 (in $100 million)
Source:PharmaceuticalsRubik's Cube, Corporate Financial Reports
Source: PharmCube